Universidade de Lisboa, Faculdade de Medicina
DC-THERA Third PartyAP112
The Instituto de Medicina Molecular (IMM) is a research institute located in the campus of the University of Lisbon Medical School and of the Santa Maria Hospital, which has acquired the special status of Laboratório Associado from the Portuguese Ministry of Science and Higher Education. IMM is a non-profit private research Institute created in 2004, mainly supported by national public funds, European Union funds, and private foundations. The mission of IMM is to foster basic, clinical and translational biomedical research with the aim of contributing to a better understanding of disease mechanisms, developing novel predictive tests, diagnostics and therapeutic approaches. IMM hosts 31 independent research groups (circa 350 researchers), whose wide range of interests fall within three major research lines: Molecular & Developmental Biology, Immunology & Infection, and Neurosciences. The proximity with the Hospital and the Medical School creates privileged opportunities to bridge with “bedside” research, promoting translational research. In addition, the institute hosts and collaborates with a number of start-up and biotechnology companies in areas of biomedical technologies and sophisticated health care delivery. IMM is committed to excellence in Science. This goal is pursued by developing coherent R&D activities, an advanced training program, and the recruitment of outstanding international young group leaders to establish leading research teams in Biomedicine. The thrive for excellence is also reflected in the international collaborations established by IMM research teams, and by the high profile international grants list awarded to IMM researchers (http://www.imm.fm.ul.pt).
Persons:
-
Luis Graca
Scientific responsible